Exploratory analysis of comparative clinical trials used for marketing approval in patients with type 2 diabetes in Japan

BACKGROUND/OBJECTIVES: The results of phase 2 and 3 clinical trials, which justify decisions regarding marketing approval for new drugs, are used for comparison of drugs in the post-marketing phase. A number of meta-analyses of approved antidiabetics have been performed, but the heterogeneity of tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneko, Reina, Ono, Shunsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329034/
https://www.ncbi.nlm.nih.gov/pubmed/30671243
http://dx.doi.org/10.1177/2050312118823407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329034/
https://www.ncbi.nlm.nih.gov/pubmed/30671243
http://dx.doi.org/10.1177/2050312118823407

Ejemplares similares